The purification and separation of the product of interest from process- and product-related impurities remains a major challenge in development.
Matica Biotechnology, Inc., a CDMO specializing in viral vector production, and Cirsium Biosciences, a biotechnology company developing a plant-based AAV (adeno-associated virus) technology, entered a ...